- Dividend Yield (FWD)
- 1.07%
- Annual Payout (FWD)
- ₩1,100.00
- Dividend Growth Rate (CAGR)
As an aristocrat you get access to the dividend growth rate and all important dividend figures tailored to your portfolio.
Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
₩1,100 | 15.5% | ||
₩1,100 | 15.5% | ||
₩952.381 | 5% | ||
₩952.381 | 5% | ||
₩907.0295 | 10.25% | ||
₩822.7024 | 16.67% | ||
₩705.1736 | 0% | ||
₩705.1735 |
Chong Kun Dang Pharmaceutical Corp pays a dividend yield (FWD) of 1.07%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XKRX
- Value
- €69.00
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
South Korea
- Dividend Currency
- South Korean Won
- Within the last 12 months, Chong Kun Dang Pharmaceutical Corp paid a dividend of ₩1,100. For the next 12 months, Chong Kun Dang Pharmaceutical Corp is expected to pay a dividend of ₩1,100. This corresponds to a dividend yield of approximately 1.07%.
- The dividend yield of Chong Kun Dang Pharmaceutical Corp is currently 1.07%.
- Chong Kun Dang Pharmaceutical Corp pays annually dividends. Payout is in April.
- The next dividend for Chong Kun Dang Pharmaceutical Corp is expected in April.
- Within the last 10 years, Chong Kun Dang Pharmaceutical Corp has paid dividends in 6 of them.
- Dividends of ₩1,100 are expected for the next 12 months. This corresponds to a dividend yield of 1.07%.
- Chong Kun Dang Pharmaceutical Corp is assigned to the sector "Health Care".
- The last stock split of Chong Kun Dang Pharmaceutical Corp was on December 28, 2022 in the ratio 1:1.
- To receive the last dividend of Chong Kun Dang Pharmaceutical Corp on April 5, 2024 in the amount of ₩1,100 you had to have the stock in your portfolio before the ex-day on December 27, 2023.
- The last dividend was paid on April 5, 2024.
- In 2022, dividends of ₩907 were paid by Chong Kun Dang Pharmaceutical Corp.
- Dividends from Chong Kun Dang Pharmaceutical Corp are paid in South Korean Won.
- The headquarters of Chong Kun Dang Pharmaceutical Corp is located in South Korea.